Literature DB >> 32488412

Usefulness of immunohistochemistry to distinguish between secretory carcinoma and acinic cell carcinoma in the salivary gland.

Yuichiro Hamamoto1,2, Hiroshi Harada2, Masaharu Kohara1, Keiichiro Honma2, Shin-Ichi Nakatsuka3, Eiichi Morii4.   

Abstract

Secretory carcinoma (SC) of the salivary gland is a relatively newly described disease, separate from acinic cell carcinoma (ACC), which frequently displays ETV6-NTRK3 gene fusion. However, the differences between SC and ACC remain unclear. Here, histological reevaluation of 12 formerly diagnosed ACC cases was performed, which yielded a new diagnosis of SC in four cases due to a lack of obvious acinar-like cells. Immunohistochemically, phosphorylated signal transducer and activator of transcription 5 (p-STAT5) was expressed in SC but not in ACC, whereas discovered on GIST-1 (DOG1) was expressed in ACC but not in SC. Molecular analysis was possible in three SC cases, of which two showed the ETV6-NTRK3 fusion transcript on reverse-transcription polymerase chain reaction, as well as breaks in the ETV6 gene on fluorescence in situ hybridization. However, the remaining SC cases did not show this fusion transcript. Recently, several reports have suggested that SC might not be adequately diagnosed if the focus is placed solely on the ETV6-NTRK3 fusion gene due to genetic diversity. In this regard, immunohistochemistry of p-STAT5 and DOG1 is expected to be a useful alternative diagnostic tool to discriminate SC from ACC.

Entities:  

Keywords:  Acinic cell carcinoma; ETV6-NTRK3; Phosphorylated signal transducer and activator of transcription 5; Salivary gland; Secretory carcinoma

Mesh:

Substances:

Year:  2020        PMID: 32488412     DOI: 10.1007/s00795-020-00256-4

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.070


  21 in total

1.  The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma.

Authors:  Simion I Chiosea; Christopher Griffith; Adel Assaad; Raja R Seethala
Journal:  Am J Surg Pathol       Date:  2012-03       Impact factor: 6.394

2.  Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.

Authors:  Justin A Bishop; Raluca Yonescu; Denise Batista; Shahnaz Begum; David W Eisele; William H Westra
Journal:  Hum Pathol       Date:  2013-06-14       Impact factor: 3.466

3.  Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic and molecular study including 2 cases harboring ETV6-X fusion.

Authors:  Yohei Ito; Kenichiro Ishibashi; Ayako Masaki; Kana Fujii; Yukio Fujiyoshi; Hideo Hattori; Daisuke Kawakita; Manabu Matsumoto; Satoru Miyabe; Kazuo Shimozato; Toshitaka Nagao; Hiroshi Inagaki
Journal:  Am J Surg Pathol       Date:  2015-05       Impact factor: 6.394

4.  Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family.

Authors:  Julie Guilmette; Dora Dias-Santagata; Vânia Nosé; Jochen K Lennerz; Peter M Sadow
Journal:  Hum Pathol       Date:  2018-08-18       Impact factor: 3.466

5.  Salivary Secretory Carcinoma With a Novel ETV6-MET Fusion: Expanding the Molecular Spectrum of a Recently Described Entity.

Authors:  Lisa M Rooper; Theodoros Karantanos; Yi Ning; Justin A Bishop; Sarah W Gordon; Hyunseok Kang
Journal:  Am J Surg Pathol       Date:  2018-08       Impact factor: 6.394

6.  Clinicopathologic and molecular characterization of mammary analogue secretory carcinoma of salivary gland origin.

Authors:  F Baghai; F Yazdani; A Etebarian; A Garajei; A Skalova
Journal:  Pathol Res Pract       Date:  2017-07-23       Impact factor: 3.250

Review 7.  Cancers of the Major Salivary Gland.

Authors:  Eugene Son; Aru Panwar; Charles H Mosher; Daniel Lydiatt
Journal:  J Oncol Pract       Date:  2018-02       Impact factor: 3.840

8.  Diagnostic utility of phosphorylated signal transducer and activator of transcription 5 immunostaining in the diagnosis of mammary analogue secretory carcinoma of the salivary gland: A comparative study of salivary gland cancers.

Authors:  Akihiko Kawahara; Tomoki Taira; Hideyuki Abe; Yorihiko Takase; Takashi Kurita; Eiji Sadashima; Satoshi Hattori; Ichio Imamura; Shinji Matsumoto; Hitomi Fujisaki; Kazunobu Sueyoshi; Jun Akiba; Masayoshi Kage
Journal:  Cancer Cytopathol       Date:  2015-08-07       Impact factor: 5.284

9.  Molecular Profiling of Mammary Analog Secretory Carcinoma Revealed a Subset of Tumors Harboring a Novel ETV6-RET Translocation: Report of 10 Cases.

Authors:  Alena Skalova; Tomas Vanecek; Petr Martinek; Ilan Weinreb; Todd M Stevens; Roderick H W Simpson; Martin Hyrcza; Niels J Rupp; Martina Baneckova; Michael Michal; David Slouka; Tomas Svoboda; Alena Metelkova; Arghavan Etebarian; Jaroslav Pavelka; Steven J Potts; Jason Christiansen; Petr Steiner; Michal Michal
Journal:  Am J Surg Pathol       Date:  2018-02       Impact factor: 6.394

10.  Mammary Analogue Secretory Carcinoma of Salivary Glands: Molecular Analysis of 25 ETV6 Gene Rearranged Tumors With Lack of Detection of Classical ETV6-NTRK3 Fusion Transcript by Standard RT-PCR: Report of 4 Cases Harboring ETV6-X Gene Fusion.

Authors:  Alena Skálová; Tomas Vanecek; Roderick H W Simpson; Jan Laco; Hanna Majewska; Martina Baneckova; Petr Steiner; Michal Michal
Journal:  Am J Surg Pathol       Date:  2016-01       Impact factor: 6.394

View more
  2 in total

1.  Clinicopathological characteristics and outcomes of 23 patients with secretory carcinoma of major salivary glands.

Authors:  Jingjing Sun; Sirui Liu; Kun Fu; Ning Gao; Rui Li; Wei He; Zhenjie Gao
Journal:  Sci Rep       Date:  2021-11-22       Impact factor: 4.379

Review 2.  DOG1 as an Immunohistochemical Marker of Acinic Cell Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Vincenzo Fiorentino; Patrizia Straccia; Pietro Tralongo; Teresa Musarra; Francesco Pierconti; Maurizio Martini; Guido Fadda; Esther Diana Rossi; Luigi Maria Larocca
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.